NCT07058116 - Accelerator-based BNCT (Boron Neutron Capture Therapy) for Head and Neck Carcinoma. | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

May 8, 2025

Primary Completion Date

November 30, 2025

Study Completion Date

January 30, 2026

Conditions

Head and Neck Carcinoma

Interventions

DRUG

L-Boronophenylalanine intravenous administration

L-BPA will be complexed with fructose to form L-BPA-fructose (L-BPA-F) to increase solubility, and 400 mg/kg of L-BFA as complexed with fructose (L-BPA-F) will then be administered intravenously at a concentration of L-BPA 30 g/L over 2 hours before neutron irradiation.

Trial Locations (1)

00290

RECRUITING

Helsinki University Hospital, Helsinki